| Name: | Axitinib Impurity H |
| Catalogue No. | VL4110008 |
| CAS No. | 1639137-80-6 |
| Molecular Formula | C24H20N4O2S |
| Molecular Weight | 428.51 |
| Status | In-stock |
| IUPAC Name | (E)-2-((1-acetyl-3-(2-(pyridin-2-yl)vinyl)-1H-indazol-6-yl)thio)-N-methylbenzamide |
| Description | Axitinib Impurity H(CAS No: 1639137-80-6) or (E)-2-((1-acetyl-3-(2-(pyridin-2-yl)vinyl)-1H-indazol-6-yl)thio)-N-methylbenzamide.Axitinib Impurity H is an impurity of Axitinib. it is an oral and selective tyrosine kinase inhibitor that is used to treatment of renal cell carcinoma |
| References | Chen, Ying, et al. “Clinical Pharmacology of Axitinib.” Clinical Pharmacokinetics, vol. 52, no. 9, 1 Sept. 2013, pp. 713–725, link.springer.com/article/10.1007%2Fs40262-013-0068-3, 10.1007/s40262-013-0068-3. Accessed 6 May 2021. |
